BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 28405672)

  • 1. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
    Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
    Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin.
    Barale C; Frascaroli C; Cavalot F; Russo I
    Thromb Res; 2019 Aug; 180():74-85. PubMed ID: 31229924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
    Russo I; Viretto M; Barale C; Mattiello L; Doronzo G; Pagliarino A; Cavalot F; Trovati M; Anfossi G
    Diabetes; 2012 Nov; 61(11):2913-21. PubMed ID: 22837307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
    Wu X; Li S; Xue P; Li Y
    Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism.
    Riba R; Oberprieler NG; Roberts W; Naseem KM
    J Thromb Haemost; 2006 Dec; 4(12):2636-44. PubMed ID: 17100655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.
    Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K
    Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
    Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
    Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
    Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide.
    Riba R; Patel B; Aburima A; Naseem KM
    J Thromb Haemost; 2008 Dec; 6(12):2121-31. PubMed ID: 18983522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
    Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
    Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor action in the vasculature.
    Almutairi M; Al Batran R; Ussher JR
    Peptides; 2019 Jan; 111():26-32. PubMed ID: 30227157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.
    Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J
    Peptides; 2020 Feb; 124():170212. PubMed ID: 31770577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease.
    Foer D; Amin T; Nagai J; Tani Y; Feng C; Liu T; Newcomb DC; Lai J; Hayashi H; Snyder WE; McGill A; Lin A; Laidlaw TM; Niswender KD; Boyce JA; Cahill KN
    J Immunol; 2023 Dec; 211(12):1806-1813. PubMed ID: 37870292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.